Quest Diagnostics (DGX) Consolidated Net Income: 2009-2025
Historic Consolidated Net Income for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $251.0 million.
- Quest Diagnostics' Consolidated Net Income rose 8.66% to $251.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $986.0 million, marking a year-over-year increase of 13.59%. This contributed to the annual value of $902.0 million for FY2024, which is 2.27% up from last year.
- Latest data reveals that Quest Diagnostics reported Consolidated Net Income of $251.0 million as of Q3 2025, which was down 12.54% from $287.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Consolidated Net Income registered a high of $640.0 million during Q2 2021, and its lowest value of $113.0 million during Q4 2022.
- Over the past 3 years, Quest Diagnostics' median Consolidated Net Income value was $231.0 million (recorded in 2024), while the average stood at $230.8 million.
- In the last 5 years, Quest Diagnostics' Consolidated Net Income skyrocketed by 414.13% in 2021 and then slumped by 70.88% in 2022.
- Quarterly analysis of 5 years shows Quest Diagnostics' Consolidated Net Income stood at $388.0 million in 2021, then slumped by 70.88% to $113.0 million in 2022, then surged by 74.34% to $197.0 million in 2023, then grew by 17.26% to $231.0 million in 2024, then climbed by 8.66% to $251.0 million in 2025.
- Its last three reported values are $251.0 million in Q3 2025, $287.0 million for Q2 2025, and $217.0 million during Q1 2025.